1 of Wall Street’s Favorite Stock Worth Your Attention and 2 to Question The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory. Unlike the investment banks, we created StockStory to provide independent analysis that helps you determine which companies are truly worth following. Keeping that in mind, here is one stock where Wall Street’s excitement appears well-founded and two where consensus estimates seem disconnected from reality. Two Stocks to Sell: Marriott (MAR) Consensus Price Target: $283.58 (25.8% implied return) Founded by J. Willard Marriott in 1927, Marriott International (NASDAQ:MAR) is a global hospitality company with a portfolio of over 7,000 properties and 30 brands, spanning 130+ countries and territories. Why Is MAR Not Exciting? Revenue per room has disappointed over the past two years due to weaker trends in its daily rates and occupancy levels Estimated sales growth of 4.2% for the next 12 months implies demand will slow from its two-year trend Earnings per share lagged its peers over the last five years as they only grew by 9.2% annually At $218.52 per share, Marriott trades at 20.2x forward price-to-earnings. Check out our free in-depth research report to learn more about why MAR doesn’t pass our bar. Pangaea (PANL) Consensus Price Target: $9.38 (124% implied return) Established in 1996, Pangaea Logistics (NASDAQ:PANL) specializes in global logistics and transportation services, focusing on the shipment of dry bulk cargoes. Why Do We Think PANL Will Underperform? Products and services are facing significant end-market challenges during this cycle as sales have declined by 12.4% annually over the last two years Issuance of new shares over the last two years caused its earnings per share to fall by 40.2% annually, even worse than its revenue declines Free cash flow margin dropped by 5.4 percentage points over the last five years, implying the company became more capital intensive as competition picked up Pangaea’s stock price of $4.19 implies a valuation ratio of 3.9x forward price-to-earnings. To fully understand why you should be careful with PANL, check out our full research report (it’s free). One Stock to Watch: BioMarin Pharmaceutical (BMRN) Consensus Price Target: $96.16 (65% implied return) Pioneering treatments for conditions that often had no previous therapeutic options, BioMarin Pharmaceutical (NASDAQ:BMRN) develops and commercializes therapies that address the root causes of rare genetic disorders, particularly those affecting children. Story Continues Why Are We Positive On BMRN? Annual revenue growth of 16.7% over the last two years was superb and indicates its market share increased during this cycle Performance over the past five years shows its incremental sales were extremely profitable, as its annual earnings per share growth of 30.8% outpaced its revenue gains Free cash flow margin grew by 18.6 percentage points over the last five years, giving the company more chips to play with BioMarin Pharmaceutical is trading at $58.70 per share, or 14.6x forward price-to-earnings. Is now the right time to buy? Find out in our full research report, it’s free. Stocks We Like Even More The market surged in 2024 and reached record highs after Donald Trump’s presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025. While the crowd speculates what might happen next, we’re homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver’s seat and build a durable portfolio by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 175% over the last five years. Stocks that made our list in 2019 include now familiar names such as Nvidia (+2,183% between December 2019 and December 2024) as well as under-the-radar businesses like Sterling Infrastructure (+1,096% five-year return). Find your next big winner with StockStory today for free. View Comments
1 of Wall Street’s Favorite Stock Worth Your Attention and 2 to Question
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...